The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,128,413 in first-year total cost, median $233,625.
Most frequent study sections
- Special Emphasis Panel[ZRG1 DKUS-L (55)]12
- Special Emphasis Panel[ZRG1 DKUS-J (56)]2
Most frequent institutions
- UNIVERSITY OF COLORADO DENVER2
- BAYLOR RESEARCH INSTITUTE1
- CHILDREN'S HOSP OF PHILADELPHIA1
- EMORY UNIVERSITY1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Breaking down care process and patient-level barriers to arteriovenous access creation prior to hemodialysis initiation1R21DK116115-01A1 | BOULWARE, LEIGH EFLYTHE, JENNIFER EGREEN, JAMIE ALTON | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $269,601 | ZRG1 |
| 2018 | An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury: A Randomized Trial of an Early Standardized, Personalized Nephrology Intervention1R21DK113420-01A1 | KOYNER, JAY L | UNIVERSITY OF CHICAGO, IL | $243,000 | ZRG1 |
| 2018 | Reducing chronic kidney disease burden in an underserved population1R21DK113440-01A1 | WESSON, DONALD E | BAYLOR RESEARCH INSTITUTE, TX | $240,645 | ZRG1 |
| 2018 | Immunoparalysis in AKI after cardiac surgery1R21DK114444-01A1 | FAUBEL, SARAH G | UNIVERSITY OF COLORADO DENVER, CO | $223,260 | ZRG1 |
| 2018 | Fenoldopam to prevent renal dysfunction in indomethacin treated preterm infants1R21DK113073-01A1 | DAGLE, JOHN M | UNIVERSITY OF IOWA, IA | $190,408 | ZRG1 |
| 2018 | Skeletal Outcomes in Children and Young Adults with Glomerular Disease1R21DK116151-01 | DENBURG, MICHELLE | CHILDREN'S HOSP OF PHILADELPHIA, PA | $129,000 | ZRG1 |
| 2017 | A pilot study to target out-of-dialysis-unit versus dialysis-unit blood pressure1R21DK114213-01 | BANSAL, NISHAHSU, CHI-YUAN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $254,993 | ZRG1 |
| 2017 | Circulating Renal-Protective Mediators in Cardiac Surgery Patients1R21DK112105-01A1 | KINSEY, GILBERT RLYNCH, KEVIN R.ROSNER, MITCHELL H. | UNIVERSITY OF VIRGINIA, VA | $241,500 | ZRG1 |
| 2017 | Novel paradigm to improve inflammatory burden in ESRD1R21DK108076-01A1 | IOANNIDOU, EFTHIMIA | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT | $239,250 | ZRG1 |
| 2017 | Social stress, inflammation, and chronic kidney disease among african americans1R21DK112108-01A1 | ARRIOLA, KIMBERLY RUTH JACOB | EMORY UNIVERSITY, GA | $234,000 | ZRG1 |
| 2016 | Feasibility study of metformin therapy in ADPKD1R21DK107969-01A1 | BROSNAHAN, GODELA M | UNIVERSITY OF COLORADO DENVER, CO | $233,250 | ZRG1 |
| 2016 | Sit Less, Interact, Move More (SLIMM) intervention for sedentary behavior in CKD1R21DK106574-01A1 | BEDDHU, SRINIVASAN | UNIVERSITY OF UTAH, UT | $226,500 | ZRG1 |
| 2016 | Behavioral Management of Phosphorus in Hemodialysis1R21DK105437-01A1 | SEVICK, MARY A | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $211,756 | ZRG1 |
| 2016 | Randomized, Controlled Pilot Study of Rifaximin Therapy in Chronic Kidney Disease1R21DK108093-01A1 | STUBBS, JASON | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $191,250 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.